Suppr
超能文献

Targeting CD47: NO limit on therapeutic potential.

作者信息

Kaczorowski David J, Billiar Timothy R

出版信息

Circ Res. 2007 Mar 16;100(5):602-3. doi: 10.1161/01.RES.0000261609.44977.25.

DOI:10.1161/01.RES.0000261609.44977.25

PMID:17363705

Abstract

摘要

相似文献

Targeting CD47: NO limit on therapeutic potential.

Circ Res. 2007 Mar 16;100(5):602-3. doi: 10.1161/01.RES.0000261609.44977.25.

Blocking thrombospondin-1/CD47 signaling alleviates deleterious effects of aging on tissue responses to ischemia.

Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2582-8. doi: 10.1161/ATVBAHA.107.155390. Epub 2007 Oct 4.

Enhancing cardiovascular dynamics by inhibition of thrombospondin-1/CD47 signaling.

Curr Drug Targets. 2008 Oct;9(10):833-41. doi: 10.2174/138945008785909338.

Secreted Thrombospondin-1 Regulates Macrophage Interleukin-1β Production and Activation through CD47.

Sci Rep. 2016 Jan 27;6:19684. doi: 10.1038/srep19684.

A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer.

Oncotarget. 2016 Mar 1;7(9):10133-52. doi: 10.18632/oncotarget.7100.

Upregulation of thrombospondin-1(TSP-1) and its binding partners, CD36 and CD47, in sporadic inclusion body myositis.

J Neuroimmunol. 2007 Jul;187(1-2):166-74. doi: 10.1016/j.jneuroim.2007.04.022. Epub 2007 Jun 18.

Increasing survival of ischemic tissue by targeting CD47.

Circ Res. 2007 Mar 16;100(5):712-20. doi: 10.1161/01.RES.0000259579.35787.4e. Epub 2007 Feb 9.

Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies.

Nat Rev Cancer. 2009 Mar;9(3):182-94. doi: 10.1038/nrc2561. Epub 2009 Feb 5.

Escherichia coli K1 promotes the ligation of CD47 with thrombospondin-1 to prevent the maturation of dendritic cells in the pathogenesis of neonatal meningitis.

J Immunol. 2010 Sep 1;185(5):2998-3006. doi: 10.4049/jimmunol.1001296. Epub 2010 Jul 30.

Thrombospondin-1 and CD47 regulation of cardiac, pulmonary and vascular responses in health and disease.

Matrix Biol. 2014 Jul;37:92-101. doi: 10.1016/j.matbio.2014.01.002. Epub 2014 Jan 11.

引用本文的文献

Evaluating the impact of type 2 diabetes mellitus on pulmonary vascular function and the development of pulmonary fibrosis.

Front Endocrinol (Lausanne). 2024 Jul 10;15:1431405. doi: 10.3389/fendo.2024.1431405. eCollection 2024.

Engineered Cell Membrane-Derived Nanoparticles in Immune Modulation.

Adv Sci (Weinh). 2021 Dec;8(24):e2102330. doi: 10.1002/advs.202102330. Epub 2021 Oct 24.

Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.

EBioMedicine. 2020 Jul;57:102849. doi: 10.1016/j.ebiom.2020.102849. Epub 2020 Jun 21.

CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer.

Cancer Med. 2015 Sep;4(9):1322-33. doi: 10.1002/cam4.478. Epub 2015 Jun 16.

Diminished adhesion and activation of platelets and neutrophils with CD47 functionalized blood contacting surfaces.

Biomaterials. 2012 Aug;33(24):5803-11. doi: 10.1016/j.biomaterials.2012.04.051. Epub 2012 May 20.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

Targeting CD47: NO limit on therapeutic potential.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译